Ameren (AEE) EBITDA (2009 - 2026)

Ameren's EBITDA history runs 18 years deep, the most recent figure standing at $532.0 million for Q1 2026.

• On a quarterly basis, EBITDA rose 23.72% year-over-year to $532.0 million in Q1 2026; TTM through Mar 2026 was $2.1 billion, a 35.11% increase from a year earlier, with the FY2025 full-year figure at $2.0 billion, up 33.64% from the prior year.
• EBITDA advanced to $532.0 million in Q1 2026 per AEE's latest filing, from $360.0 million in the prior quarter.
• Across five years, EBITDA topped out at $825.0 million in Q3 2025 and bottomed at $198.0 million in Q4 2024.
• The 5-year median for EBITDA is $361.0 million (2024), against an average of $420.4 million.
• Across the five-year window, EBITDA fell 25.0% in 2024 and soared 81.82% in 2025, its largest moves.
• Year by year, EBITDA stood at $276.0 million in 2022, then retreated by 4.35% to $264.0 million in 2023, then decreased by 25.0% to $198.0 million in 2024, then surged by 81.82% to $360.0 million in 2025, then jumped by 47.78% to $532.0 million in 2026.
• Per Business Quant, the three latest AEE EBITDA figures stand at $532.0 million (Q1 2026), $360.0 million (Q4 2025), and $825.0 million (Q3 2025).